13 December 2018 08:46 CET

Karo Intressenter AB extends the acceptance period for its offer to the shareholders in Karo Pharma Aktiebolag

#EQT VIII #Karo Pharma

Fore more information, click here.

Latest news

11 September 2024
EQT Life Sciences leads EUR 93 million oversubscribed Series A round in Pantera, which aims to accelerate global actinium-225 production
10 September 2024
EQT deltar i Sveriges näringslivsdelegation till klimattoppmötet COP
09 September 2024
EQT to acquire GeBBS Healthcare Solutions, a leading healthcare technology solutions provider
03 September 2024
Henry Steinberg Named Global Head of EQT Exeter
26 August 2024
Repurchases of shares by EQT AB during week 34, 2024. The current share buyback program has been finalized